BioNTech SE (BNTX) Inventory (2018 - 2025)

BioNTech SE has disclosed Inventory across 8 years of filings, most recently posting $128.9 million for Q4 2025.

• Inventory for Q4 2025 came in at $128.9 million, down 57.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $128.9 million (down 57.43% YoY), and the FY2025 annual result was $125.1 million, down 58.69% from the prior year.
• Inventory came in at $128.9 million for Q4 2025 at BioNTech SE, down from $263.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $574.8 million in Q4 2021 to a low of $128.9 million in Q4 2025.
• The 5-year median for Inventory is $370.7 million (2024), against an average of $360.3 million.
• Across the five-year window, Inventory jumped 652.16% in 2021 and sank 57.43% in 2025, its largest moves.
• BioNTech SE's Inventory stood at $574.8 million in 2021, then declined by 21.98% to $448.5 million in 2022, then fell by 14.19% to $384.9 million in 2023, then decreased by 21.34% to $302.7 million in 2024, then tumbled by 57.43% to $128.9 million in 2025.
• The last three Inventory figures came in at $128.9 million (Q4 2025), $263.9 million (Q3 2025), and $261.1 million (Q2 2025), per Business Quant data.